Literature DB >> 8377583

Plasma clearance and hepatic utilization of stearic, myristic and linoleic acids introduced via chylomicrons in rats.

S Wang1, S I Koo.   

Abstract

The primary objective of the present study was to compare the rates of plasma clearance and hepatic utilization of stearic (18:0), myristic (14:0) and linoleic (18:2) acids, as introduced via chylomicrons. Lymph chylomicrons were specifically labeled in vivo with [14C]stearic and (SA), [14C]myristic acid (MA), or [14C]linoleic acid (LA) by infusing donor rats intraduodenally with the labeled fatty acids in a lipid emulsion. Following intravenous injection of recipient rats with the labeled chylomicrons, the rates of plasma clearance and incorporation of the label in triglycerides (TG), phospholipids (PL) and other lipids in the liver were compared at 5, 15 and 30 min. [14C]SA was cleared at a slightly faster rate (t1/2 = 7.0 min) than [14C]MA (t1/2 = 8.1 min) and [14C]LA (t1/2 = 8.0 min) (P < 0.05). [14C]SA was accumulated in the liver at a significantly faster rate than [14C]MA and [14C]LA. At the peak (15 min) of hepatic uptake, 30.3% of [14C]SA, 26.2% of [14C]LA and 21.9% of [14C]MA were recovered in the liver. At 30 min, 33.5% of [14C]SA was taken up by the liver, whereas 27.8% of [14]LA and only 15.2% of [14C]MA were removed. In the liver, the percentage of [14C]SA incorporated into PL steadily increased with time, whereas the percent-age incorporated into TG decreased. [14C]SA was preferentially incorporated into PL at all time intervals, as compared with [14C]MA and [14C]LA. At 30 min, 38.6% of [14C]SA was found in PL, and only 5.2% of [14C]MA and 12.0% of [14C]LA were present in PL.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8377583     DOI: 10.1007/bf02535989

Source DB:  PubMed          Journal:  Lipids        ISSN: 0024-4201            Impact factor:   1.880


  31 in total

1.  Report of the American Institute of Nurtition ad hoc Committee on Standards for Nutritional Studies.

Authors: 
Journal:  J Nutr       Date:  1977-07       Impact factor: 4.798

2.  Interaction of dietary cholesterol and triglycerides in the regulation of hepatic low density lipoprotein transport in the hamster.

Authors:  D K Spady; J M Dietschy
Journal:  J Clin Invest       Date:  1988-02       Impact factor: 14.808

3.  Quantitative effects of dietary fat on serum cholesterol in man.

Authors:  D M Hegsted; R B McGandy; M L Myers; F J Stare
Journal:  Am J Clin Nutr       Date:  1965-11       Impact factor: 7.045

4.  Metabolism of palmitic and linoleic acids in man: differences in turnover and conversion to glycerides.

Authors:  P J Nestel; P Barter
Journal:  Clin Sci       Date:  1971-04       Impact factor: 6.124

Review 5.  Intestinal lipoprotein metabolism.

Authors:  P H Green; R M Glickman
Journal:  J Lipid Res       Date:  1981-11       Impact factor: 5.922

6.  A comparison of absorption of glycerol tristearate and glycerol trioleate by rat small intestine.

Authors:  S E Bergstedt; H Hayashi; D Kritchevsky; P Tso
Journal:  Am J Physiol       Date:  1990-09

7.  Intestinal absorption of stearic acid after consumption of high fat meals in humans.

Authors:  A Bonanome; S M Grundy
Journal:  J Nutr       Date:  1989-11       Impact factor: 4.798

8.  Effects of fats high in stearic acid on lipid and lipoprotein concentrations in men.

Authors:  M A Denke; S M Grundy
Journal:  Am J Clin Nutr       Date:  1991-12       Impact factor: 7.045

9.  In vivo incorporation of labeled fatty acids in rat liver lipids after oral administration.

Authors:  J Leyton; P J Drury; M A Crawford
Journal:  Lipids       Date:  1987-08       Impact factor: 1.880

10.  Saturation and suppression of hepatic lipoprotein receptors: a mechanism for the hypercholesterolemia of cholesterol-fed rabbits.

Authors:  P T Kovanen; M S Brown; S K Basu; D W Bilheimer; J L Goldstein
Journal:  Proc Natl Acad Sci U S A       Date:  1981-03       Impact factor: 11.205

View more
  7 in total

1.  Metabolic fate of oleic acid, palmitic acid and stearic acid in cultured hamster hepatocytes.

Authors:  J S Bruce; A M Salter
Journal:  Biochem J       Date:  1996-06-15       Impact factor: 3.857

2.  Modulation of hepatic apolipoprotein B, 3-hydroxy-3-methylglutaryl-CoA reductase and low-density lipoprotein receptor mRNA and plasma lipoprotein concentrations by defined dietary fats. Comparison of trimyristin, tripalmitin, tristearin and triolein.

Authors:  A J Bennett; M A Billett; A M Salter; E H Mangiapane; J S Bruce; K L Anderton; C B Marenah; N Lawson; D A White
Journal:  Biochem J       Date:  1995-10-01       Impact factor: 3.857

3.  Preservation of hepatocyte nuclear factor-4α contributes to the beneficial effect of dietary medium chain triglyceride on alcohol-induced hepatic lipid dyshomeostasis in rats.

Authors:  Qiong Li; Wei Zhong; Yunping Qiu; Xinqin Kang; Xiuhua Sun; Xiaobing Tan; Yantao Zhao; Xinguo Sun; Wei Jia; Zhanxiang Zhou
Journal:  Alcohol Clin Exp Res       Date:  2012-11-05       Impact factor: 3.455

4.  Irvingia gabonensis fat: nutritional properties and effect of increasing amounts on the growth and lipid metabolism of young rats wistar sp.

Authors:  Thierry Joël Nangue; Hilaire Macaire Womeni; Felicite Tchouanguep Mbiapo; Jacques Fanni; Linder Michel
Journal:  Lipids Health Dis       Date:  2011-03-04       Impact factor: 3.876

Review 5.  Food Ingredients That Inhibit Cholesterol Absorption.

Authors:  Elliot D Jesch; Timothy P Carr
Journal:  Prev Nutr Food Sci       Date:  2017-06-30

6.  Moderate dietary intake of myristic and alpha-linolenic acids increases lecithin-cholesterol acyltransferase activity in humans.

Authors:  Carole Vaysse-Boué; Henry Dabadie; Evelyne Peuchant; Pascale Le Ruyet; François Mendy; Henry Gin; Nicole Combe
Journal:  Lipids       Date:  2007-06-13       Impact factor: 1.646

7.  Solid lipid nanoparticle formulations of docetaxel prepared with high melting point triglycerides: in vitro and in vivo evaluation.

Authors:  Youssef Wahib Naguib; B Leticia Rodriguez; Xinran Li; Stephen D Hursting; Robert O Williams; Zhengrong Cui
Journal:  Mol Pharm       Date:  2014-03-12       Impact factor: 4.939

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.